Amarantus Bioscience Holdings Inc (AMBS)

[SidVicious]

OTC isn't done yet and won't be until AMBS has all in place to uplist. That won't be for another month at the earliest. It is going to be quite the challenge for AMBS to maintain a high enough stock price. That is why we can only hope that there are deep pocket institutional buyers who believe in AMBS and will help it stay afloat and get to the next level.